These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 23337469)

  • 21. Nonadherence to antihypertensive medications amongst patients with uncontrolled hypertension: A retrospective study.
    Kulkarni S; Rao R; Goodman JDH; Connolly K; O'Shaughnessy KM
    Medicine (Baltimore); 2021 Apr; 100(14):e24654. PubMed ID: 33832064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of isolated uncontrolled systolic blood pressure among treated hypertensive patients in primary care in Belgium: results of the I-inSYST survey.
    Van der Niepen P; Giot C; van de Borne P
    J Hypertens; 2008 Oct; 26(10):2057-63. PubMed ID: 18806631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation and pharmacologic approach to patients with resistant hypertension.
    Adams M; Bellone JM; Wright BM; Rutecki GW
    Postgrad Med; 2012 Jan; 124(1):74-82. PubMed ID: 22314117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy.
    Waeber B; Feihl F
    EuroIntervention; 2013 May; 9 Suppl R():R29-34. PubMed ID: 23732152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis.
    Tomaszewski M; White C; Patel P; Masca N; Damani R; Hepworth J; Samani NJ; Gupta P; Madira W; Stanley A; Williams B
    Heart; 2014 Jun; 100(11):855-61. PubMed ID: 24694797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE.
    Düsing R; Handrock R; Klebs S; Tousset E; Vrijens B
    J Hypertens; 2009 Apr; 27(4):894-901. PubMed ID: 19300114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managing 'resistance': is adherence a target for treatment?
    Burnier M
    Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):439-43. PubMed ID: 25036746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.
    Leenen FH; Wilson TW; Bolli P; Larochelle P; Myers M; Handa SP; Boileau G; Tanner J
    Can J Cardiol; 1997 Oct; 13(10):914-20. PubMed ID: 9374947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients.
    Hamdidouche I; Jullien V; Boutouyrie P; Billaud E; Azizi M; Laurent S
    J Hypertens; 2017 Sep; 35(9):1891-1898. PubMed ID: 28505066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for uncontrolled hypertension in Italy.
    Degli Esposti E; Di Martino M; Sturani A; Russo P; Dradi C; Falcinelli S; Buda S
    J Hum Hypertens; 2004 Mar; 18(3):207-13. PubMed ID: 14973516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electronic monitoring of adherence as a tool to improve blood pressure control. A randomized controlled trial.
    Wetzels GE; Nelemans PJ; Schouten JS; Dirksen CD; van der Weijden T; Stoffers HE; Janknegt R; de Leeuw PW; Prins MH
    Am J Hypertens; 2007 Feb; 20(2):119-25. PubMed ID: 17261454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the white-coat effect among hypertensive patients presumed to be at goal.
    Bookstaver DA; Hatzigeorgiou C
    Ann Pharmacother; 2011 Jul; 45(7-8):910-5. PubMed ID: 21750311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring adherence to therapy in apparent treatment-resistant hypertension: a feasibility study in Irish primary care.
    Hayes P; Casey M; Glynn LG; Molloy GJ; Durand H; O'Brien E; Dolan E; Das K; Newell J; Finn D; Harhen B; Conneely A; Murphy AW
    Br J Gen Pract; 2019 Sep; 69(686):e621-e628. PubMed ID: 31358495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
    Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
    Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The assessment of adherence of hypertensive individuals to treatment and lifestyle change recommendations.
    Uzun S; Kara B; Yokuşoğlu M; Arslan F; Yilmaz MB; Karaeren H
    Anadolu Kardiyol Derg; 2009 Apr; 9(2):102-9. PubMed ID: 19357051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment.
    Zeller A; Schroeder K; Peters TJ
    J Clin Epidemiol; 2008 Mar; 61(3):282-8. PubMed ID: 18226752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The frequency and causes of resistant hypertension in primary care practices in the community as compared to those in the district advisory clinic for hypertension].
    Leshem S; Cohen-Lulav H; Di-Castro N; Tabenkin H; Steinmetz D
    Harefuah; 2002 Aug; 141(8):673-6, 764. PubMed ID: 12222125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
    Weisser B; Gerwe M; Braun M; Funken C
    Arzneimittelforschung; 2005; 55(9):505-13. PubMed ID: 16229114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.